---
title: "Synthetic biology concept stocks strengthen, SHENGDA BIO-PHARM hits the daily limit in the afternoon"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235355324.md"
description: "On April 10th, synthetic biology concept stocks strengthened. As of 14:23, SHENGDA BIO-PHARM hit the daily limit, Sanyuan Biotechnology, BLB, SC Pharmaceuticals, and Kingdomway had previously hit the daily limit, while Jinbo Biotechnology and Wuxi Jinghai rose over 10%"
datetime: "2025-04-10T06:27:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235355324.md)
  - [en](https://longbridge.com/en/news/235355324.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235355324.md)
generator: "portal-rs"
---

# Synthetic biology concept stocks strengthen, SHENGDA BIO-PHARM hits the daily limit in the afternoon

On April 10th, synthetic biology concept stocks strengthened. As of 14:23, SHENGDA BIO-PHARM hit the daily limit, Sanyuan Biotechnology, BLB, SC Pharmaceuticals, and Kingdomway had previously hit the daily limit, while Jinbo Biology and Wuxi Jinghai rose over 10%

### Related Stocks

- [603079.CN](https://longbridge.com/en/quote/603079.CN.md)
- [301206.CN](https://longbridge.com/en/quote/301206.CN.md)
- [002286.CN](https://longbridge.com/en/quote/002286.CN.md)
- [002693.CN](https://longbridge.com/en/quote/002693.CN.md)
- [002626.CN](https://longbridge.com/en/quote/002626.CN.md)

## Related News & Research

- [10:20 ETTEAMSTERS AT CASS-CLAY CREAMERY RATIFY CONTRACT](https://longbridge.com/en/news/296929253.md)
- [Kona BidCo Tightens Control of Zalaris With Increased Shareholding](https://longbridge.com/en/news/296951165.md)
- [Kona BidCo raises Zalaris stake to 87.36% after buying 1,621 shares at NOK 100 each](https://longbridge.com/en/news/296948768.md)
- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [16:00 ETCHRIS HEMSWORTH JOINS ARCHIE ROSE DISTILLING CO. AS CO-OWNER AHEAD OF U.S. LAUNCH AND GLOBAL EXPANSION](https://longbridge.com/en/news/296950819.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**